Grey Fox Wealth Advisors’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
S
Grey Fox Wealth Advisors's NVAX Position: Q4 2025 in Review
Grey Fox Wealth Advisors sold out of Novavax (NVAX) in Q4 2025, closing a stake of 150 shares — an estimated $1.3K sold.
Grey Fox Wealth Advisors first reported a position in NVAX in Q3 2025 and held it in 1 quarter. The position peaked at $1.3K in Q3 2025. 235 funds tracked by Wall St. Rank hold NVAX as of Q4 2025.
- Grey Fox Wealth Advisors reported no remaining Novavax position as of Q4 2025 after selling out during the quarter.
- Grey Fox Wealth Advisors sold 150 Novavax shares in Q4 2025, an estimated $1.3K.
- Grey Fox Wealth Advisors first reported a position in Novavax in Q3 2025 and held it in 1 quarter.
- Grey Fox Wealth Advisors's Novavax position peaked at $1.3K in Q3 2025.
- 235 funds tracked by Wall St. Rank held Novavax as of Q4 2025.
Based on Grey Fox Wealth Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.